Unlike classic CD8+ TILs, increased density of CD8+ TILs was indicated as a poor prognostic factor in non–small cell lung cancer, renal cell carcinoma, and hepatocellular carcinoma patients [31,32,33]. Here, CD8A is linked to lung cancer.